相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Influence of 150-Cavity Binders on the Dynamics of Influenza A Neuraminidases as Revealed by Molecular Dynamics Simulations and Combined Clustering
Kyle T. Greenway et al.
PLOS ONE (2013)
Plasticity of 150-Loop in Influenza Neuraminidase Explored by Hamiltonian Replica Exchange Molecular Dynamics Simulations
Nanyu Han et al.
PLOS ONE (2013)
Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding
Yan Wu et al.
SCIENTIFIC REPORTS (2013)
Influenza neuraminidase
Gillian M. Air
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2012)
Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility
Santosh Rudrawar et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
A distinct lineage of influenza A virus from bats
Suxiang Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site
Xueyong Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus
Qing Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis
Erhard van der Vries et al.
PLOS PATHOGENS (2012)
Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro
Masahiro Niikura et al.
ANTIVIRAL RESEARCH (2011)
Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes
Amgad Albohy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Mechanism of 150-cavity formation in influenza neuraminidase
Rommie E. Amaro et al.
NATURE COMMUNICATIONS (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses
Wen-Hsien Wen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles
Sankar Mohan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site
Qing Li et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase
Santosh Rudrawar et al.
NATURE COMMUNICATIONS (2010)
Characterizing Loop Dynamics and Ligand Recognition in Human- and Avian-Type Influenza Neuraminidases via Generalized Born Molecular Dynamics and End-Point Free Energy Calculations
Rommie E. Amaro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Limited inhibitory effects of oseltamivir and zanamivir on human sialidases
Keiko Hata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Patrick J. Collins et al.
NATURE (2008)
Synthesis of Tamiflu and its phosphonate congeners possessing potent anti-influenza activity
Jiun-Jie Shie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J. Russell et al.
NATURE (2006)
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds
DF Smee et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
LV Gubareva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
DF Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
